Media

Nordic Nanovector Appoints Experienced Pharmaceutical Business Leader Erik Skullerud as Chief Executive Officer

Aprea Therapeutics to Present Data from Phase 1/2 Trial of Eprenetapopt in Advanced Solid Tumors at ESMO Congress 2021

Precirix and IFE sign clinical trial manufacturing agreement

Oncopeptides presents phase 3 OCEAN study results at the IMW meeting

Study results on FORTIFY are inconclusive

Webcast for presentation of OCEAN data presented at IMW

Strongbridge Biopharma plc Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc.

Regulatory update from US Food and Drug Administration

Oncopeptides presents new data from OCEAN and PORT study – abstracts online